PrimeRFP SCOUT · Federal Contract Recompete Brief

W9114F23P0003BLOOD DONOR testing - reportable TESTS — Qualtex Laboratories

Qualtex Laboratories holds $1.5M across 6 federal awards, concentrated at Department of Defense (DOD). Competition previously drew 4 offers. Set-aside status: NONE. Recompete timing centers on the Apr 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

W40m Rhco Europe

Awarding office

Qualtex Laboratories

Recipient

Apr 30, 2027

PoP end

$1.5M

Obligated

$2M

Potential

621511

NAICS

Q301

PSC

NONE

Set-aside

4 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Qualtex Laboratories — $90

Contract facts

NONE

Contract numberW9114F23P0003

Also listed asW9114F-23-P-0003

AgencyW40m Rhco Europe

Awarding officeW40m Rhco Europe

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentQualtex Laboratories

CAGE669M4

UEIG3PLDLPUHU13

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

Related solicitationW9114F23Q0035

PoP startMay 1, 2023

PoP end (current)Apr 30, 2027

PoP end (w/ options)Apr 30, 2028

Obligated$1.5M

Current value$1.5M

Potential value$2M

BLOOD DONOR TESTING - REPORTABLE TESTS is a federal NONE award for W40m Rhco Europe held by Qualtex Laboratories. Estimated value $2M ($1.5M obligated). Current period of performance ends Apr 30, 2027 (potential Apr 30, 2028). Last award drew 4 bidders. Place of performance: SAN ANTONIO TX. Related solicitation W9114F23Q0035.

Recompete timing

Public

● Expiring in 235 days

Current PoP ends Apr 30, 2027 (235 days remaining). Agencies typically plan 12–18 months ahead — at 7.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Qualtex Laboratories — $1.5M obligated across 6 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$1.5M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W9114F23P0003?

W9114F23P0003 (BLOOD DONOR testing - reportable TESTS) is a W40m Rhco Europe award with a potential value of $2M, currently held by Qualtex Laboratories. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W9114F-23-P-0003?

W9114F-23-P-0003 is the dashed form of PIID W9114F23P0003 (BLOOD DONOR testing - reportable TESTS), held by Qualtex Laboratories. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W9114F23P0003?

W40m Rhco Europe awarded W9114F23P0003 to Qualtex Laboratories (potential $2M).

Who is the incumbent on W9114F23P0003?

Qualtex Laboratories is the incumbent with $1.5M across 6 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2027.

When does Qualtex Laboratories’s W9114F23P0003 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on W9114F23P0003 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Apr 13, 2026